Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05715086 · ClinicalTrials.gov registry record · NA
UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones
A NA study of Ureteral Stone, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05715086: Recruiting NA study of Ureteral Stone, sponsored by University of California, San Francisco.
NCT05715086 is a NA study of Ureteral Stone that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 167-participant average among 3 other Ureteral Stone trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05715086, a NA study of Ureteral Stone, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective, non-blinded, randomized controlled trial studying the management of symptomatic ureteral stones. This study will compare upfront ureteroscopy vs observation and delayed intervention for patients presenting to the emergency department with a symptomatic ureteral stone.
Primary Outcome
Measure on a scale of 1-10, with zero indicating no pain and 10 indicating the worst pain.
Conditions Studied
Interventions
- PROCEDURE Ureteroscopy
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05715086 shows while recruiting
NCT05715086 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 167-participant average among 3 other Ureteral Stone trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Ureteral Stone appearing as the primary indexed condition, and to 1 intervention - of which Ureteroscopy is the first listed.
NCT05715086 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05715086 about?
NCT05715086 is a clinical study titled "UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones". A prospective, non-blinded, randomized controlled trial studying the management of symptomatic ureteral stones. This study will compare upfront ureteroscopy vs observation and delayed intervention for patients presenting to the emergency department with a symptomatic ureteral stone.
What is the current status of trial NCT05715086?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-08-23. Estimated completion is 2026-06-30.
What conditions does trial NCT05715086 study?
This clinical trial studies the following conditions: Ureteral Stone.
What interventions are being tested in trial NCT05715086?
The interventions under investigation include: Ureteroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT05715086?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05715086 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ureteral Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI